Nucynta (Tapentadol Hydrochloride) - Current Clinical Trials

Nucynta Related Clinical Trials

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin [Recruiting]

NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back Pain [Recruiting]

A Study of Tapentadol Immediate-Release in the Treatment of Patients With Acute Pain From Bunionectomy [Recruiting]

A Safety and Effectiveness Study of Prolonged Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Chronic Non-Cancer Pain [Not yet recruiting]

A Safety and Effectiveness Study of Immediate Release Tapentadol Hydrochloride Among Filipino Patients With Moderate to Severe Acute Non-Cancer Pain [Not yet recruiting]

Intravenous Tapentadol in Post-Bunionectomy Pain [Recruiting]

Pharmacokinetics and Tolerability Study of Tapentadol for Postsurgical Pain in Children and Adolescents [Recruiting]

Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability [Recruiting]

Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain [Recruiting]

A Study to Evaluate CG5503 in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine [Recruiting]

Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic Pain [Recruiting]

Tapentadol in Chronic Malignant Tumour Related [Recruiting]

A Study is to Evaluate the Efficacy, Safety, and Tolerability of Orally Administered Tapentadol ER at Dosages of 100 to 250 mg Twice Daily Compared With Placebo in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN) [Recruiting]

An Efficacy and Safety Study for JNS024ER (Tapentadol ER) in Chronic Pain Patients Due to Painful Diabetic Peripheral Neuropathy or Postherpetic Neuralgia [Recruiting]

A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain [Recruiting]